ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Internal Medicine

Top Internal Medicine Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID KING M.D.

Internal Medicine

13,317

$919K

461
275 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $77

ESMERANDO JUANITEZ M.D.

Internal Medicine

10,636

$548K

314
252 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $77

MICHAEL GRADY M.D.

Internal Medicine

10,599

$547K

369
354 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

MARTA SCHNEIDER M.D.

Internal Medicine

9,401

$556K

277
263 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $77

PHILIP BIBB PAC

Internal Medicine

9,133

$544K

330
203 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

EMMANUEL MBUALUNGU MD

Internal Medicine

8,091

$527K

324
252 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

SHADI SOUFI M.D.

Internal Medicine

7,316

$469K

335
205 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $77

CYRIL ALLEN

Internal Medicine

6,939

$372K

287
131 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $77

RAFIC JARRAH MD

Internal Medicine

6,882

$459K

245
155 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $77

JERRY EARLL

Internal Medicine

6,550

$363K

115
113 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $77

BRUCE COOPER MD

Internal Medicine

6,474

$261K

382
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $77

ARREL OLANO MD

Internal Medicine

6,404

$380K

455
280 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $77

JOEL WILKERSON MD

Internal Medicine

6,220

$325K

294
209 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

GEORGES AWAH MD, PHD

Internal Medicine

6,218

$486K

305
175 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 29%

$78
Average prescription price

Avg: $77

ANDRE MICHALAK M,D.

Internal Medicine

5,995

$334K

277
221 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $77

RICHARD MCCLENDON

Internal Medicine

5,747

$350K

211
96 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $77

FITZGERALD BIRMINGHAM MD

Internal Medicine

5,501

$354K

278
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $77

EMIMANUEL BROWN M.D.

Internal Medicine

5,366

$256K

257
162 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $77

STEPHEN SEABRON M.D.

Internal Medicine

5,318

$391K

209
172 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $77

RICARDO CALDERA MD

Internal Medicine

4,856

$513K

157
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$106
Average prescription price

Avg: $77

GODWIN DARKO MD, MPH

Internal Medicine

4,668

$301K

370
226 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

SUSAN HOUSEMAN MD

Internal Medicine

4,526

$216K

335
316 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $77

EDSEL GAYOSO MD

Internal Medicine

4,402

$240K

297
267 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $77

RANDI ABRAMSON MD

Internal Medicine

4,377

$174K

166
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $77

SIMEON OBENG M.D.

Internal Medicine

4,369

$195K

236
138 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$45
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank